PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28249914
OWN - NLM
STAT- MEDLINE
DA  - 20170302
DCOM- 20170313
LR  - 20170313
IS  - 1550-8080 (Electronic)
IS  - 0091-7370 (Linking)
VI  - 47
IP  - 1
DP  - 2017 Jan
TI  - Downregulation of YAP in Clear Cell Renal Cell Carcinoma Contributes to Poor
      Prognosis and Progressive Features.
PG  - 36-39
AB  - THE GOAL: To investigate the expression of Yes-associated protein (YAP) in clear 
      cell renal cell carcinoma (ccRCC) and its clinical/prognostic significance.
      PROCEDURES: The expression of YAP protein was evaluated in tissue microarray by
      immunohistochemistry. Correlation between YAP expression and clinicopathological 
      characteristics of renal cell carcinoma was analyzed. RESULTS: Downregulation of 
      YAP protein was observed in ccRCC samples (P=0.0311). Downregulation of YAP
      expression was correlated with higher T classification, higher clinical stage,
      and poorer differentiation (P<0.05). CONCLUSIONS: Downregulation of YAP in clear 
      cell renal cell carcinoma (ccRCC) may contribute to poor prognosis and
      progressive features.
CI  - (c) 2017 by the Association of Clinical Scientists, Inc.
FAU - Hu, Xiaoyong
AU  - Hu X
AD  - Department of Urology, Shanghai Jiaotong University Affiliated 6th People's
      Hospital, Shanghai, China [email protected]
FAU - Chen, Jie
AU  - Chen J
AD  - Department of Pathology, Shanghai Jiaotong University Affiliated 6th People's
      Hospital, Shanghai Jiaotong University, Shanghai, China.
FAU - Fu, Qiang
AU  - Fu Q
AD  - Department of Urology, Shanghai Jiaotong University Affiliated 6th People's
      Hospital, Shanghai, China.
LA  - eng
PT  - Journal Article
PL  - United States
TA  - Ann Clin Lab Sci
JT  - Annals of clinical and laboratory science
JID - 0410247
RN  - 0 (Adaptor Proteins, Signal Transducing)
RN  - 0 (Phosphoproteins)
RN  - 0 (YAP1 (Yes-associated) protein, human)
SB  - IM
MH  - Adaptor Proteins, Signal Transducing/*metabolism
MH  - Carcinoma, Renal Cell/*metabolism/*pathology
MH  - *Disease Progression
MH  - *Down-Regulation
MH  - Female
MH  - Humans
MH  - Immunohistochemistry
MH  - Kidney Neoplasms/*metabolism/*pathology
MH  - Male
MH  - Middle Aged
MH  - Phosphoproteins/*metabolism
MH  - Prognosis
OTO - NOTNLM
OT  - Clear cell renal cell carcinoma (ccRCC)
OT  - Prognosis
OT  - Yes-associated protein (YAP)
EDAT- 2017/03/03 06:00
MHDA- 2017/03/14 06:00
CRDT- 2017/03/03 06:00
AID - 47/1/36 [pii]
PST - ppublish
SO  - Ann Clin Lab Sci. 2017 Jan;47(1):36-39.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>